Skip to main content

Orchestrated and dynamic nucleotide addition cycle during respiratory syncytial virus early-stage elongation.

Nature communications2026-04-30PubMed
Total: 85.5Innovation: 9Impact: 0Rigor: 0Citation: 0

Summary

High-resolution cryo-EM captures RSV polymerase across four nucleotide addition cycle states, revealing large-scale domain rearrangements and micro-motif interactions that coordinate catalysis. These structural insights identify conserved interaction networks as potential antiviral targets against RSV and related mononegavirales.

Key Findings

  • Captured four discrete NAC states (NTP-bound, pre-reaction, pre-translocation, post-translocation) of the RSV L:P polymerase during early elongation.
  • Observed all five L domains in NTP-bound and post-translocation states, versus only two domains in pre-reaction and pre-translocation.
  • Revealed dynamic interaction networks among catalytic residues/motifs, RNA template/product, incoming NTP, and metal ions across states.
  • Provides structural basis to target conserved motifs and interfaces for antiviral drug design.

Clinical Implications

Although preclinical, the defined NAC-state interaction hotspots can guide small-molecule or nucleotide analog inhibitor development, with potential translation to broad antivirals against RSV and other nonsegmented negative-sense RNA viruses.

Why It Matters

This is the first comprehensive visualization of RSV polymerase through early elongation NAC states, enabling rational, structure-guided inhibitor design against a leading pediatric pathogen.

Limitations

  • In vitro structural snapshots without in vivo validation.
  • Drug inhibition or resistance mutations were not experimentally tested in this study.

Future Directions

Integrate structure-guided medicinal chemistry to target NAC-state interfaces; validate inhibitory mechanisms in cell and animal models; assess conservation of targetable motifs across mononegavirales for pan-family antivirals.

Study Information

Study Type
Basic mechanistic study
Research Domain
Pathophysiology
Evidence Level
V - Preclinical structural biology study elucidating molecular mechanism without clinical outcomes.
Study Design
OTHER